Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation

被引：10
|
作者：
Poreba, Malgorzata [1 ]
Gac, Pawel [1 ]
Usnarska-Zubkiewicz, Lidia [2 ]
Pilecki, Witold [1 ]
Kuliczkowski, Kazimierz [2 ]
Mazur, Grzegorz [3 ]
Sobieszczanska, Malgorzata [1 ]
Poreba, Rafal [3 ]
机构：
[1] Wroclaw Med Univ, Dept Pathophysiol, Marcinkowskiego 1 St, PL-50368 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, Pasteur 4, PL-50367 Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Internal Med Occupat Dis & Hypertens, Borowska 213, PL-50556 Wroclaw, Poland
来源：
CARDIOVASCULAR TOXICOLOGY | 2016年 / 16卷 / 02期
关键词：
Ultrasonography; Brachial artery; Endothelium; Hematopoietic stem cell transplantation; ACUTE LYMPHOBLASTIC-LEUKEMIA; FLOW-MEDIATED VASODILATION; LONG-TERM SURVIVORS; BRACHIAL-ARTERY; VASCULAR FUNCTION; LATE MORTALITY; CORONARY; CARDIOTOXICITY; ANTHRACYCLINES; DYSFUNCTION;
D O I：
10.1007/s12012-015-9324-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The aim of the study was to examine endothelial function in patients with hematological malignancies treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation. The studies were conducted on 43 consecutive patients qualified for HSCT following high-dose chemotherapy based on the current standards. Then, due to exclusion criteria, a group of 38 patients were chosen for further investigations. Evaluation of endothelial function by means of flow-mediated dilatation (FMD) was conducted in patients with hematological malignancies before HSCT (test A) and after HSCT (test B). Brachial artery diameter (BAD) after occlusion, change in BAD and FMD were significantly lower after HSCT as compared to the results obtained before the transplantation (p < 0.05). The regression analysis indicated that administration of fludarabine and cytarabine, and also higher blood concentrations of creatinine represented risk factors for the impairment of endothelial function expressed as decreased FMD value. In patients with hematopoietic malignancies treated with HSCT, endothelial function assessed by the flow-mediated dilatation was impaired after chemotherapy and stem cell administration.
引用
收藏
页码：156 / 162
页数：7
相关论文
共 50 条
  • [1] Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
    Małgorzata Poręba
    Paweł Gać
    Lidia Usnarska-Zubkiewicz
    Witold Pilecki
    Kazimierz Kuliczkowski
    Grzegorz Mazur
    Małgorzata Sobieszczańska
    Rafał Poręba
    [J]. Cardiovascular Toxicology, 2016, 16 : 156 - 162
  • [2] High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation
    A Safdar
    G Rodriguez
    K V I Rolston
    S O'Brien
    I F Khouri
    E J Shpall
    M J Keating
    H M Kantarjian
    R E Champlin
    I I Raad
    D P Kontoyiannis
    [J]. Bone Marrow Transplantation, 2007, 39 : 157 - 164
  • [3] High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation
    Safdar, A.
    Rodriguez, G.
    Rolston, K. V. I.
    O'Brien, S.
    Khouri, I. F.
    Shpall, E. J.
    Keating, M. J.
    Kantarjian, H. M.
    Champlin, R. E.
    Raad, I. I.
    Kontoyiannis, D. P.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 (03) : 157 - 164
  • [4] High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with second primary malignancies
    Fetscher, S
    Finke, J
    Engelhardt, R
    Mertelsmann, R
    Lange, W
    [J]. HEMATOLOGY AND CELL THERAPY, 1997, 39 (02): : 79 - 83
  • [5] Secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Fetscher, S
    Lange, W
    Finke, J
    Bertz, E
    Mertelsmann, R
    [J]. BLOOD, 1995, 86 (10) : 3768 - 3768
  • [6] Left ventricular dysfunction in patients undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Potemkina, N. A.
    Zeynalova, P. A.
    Petrova, G. D.
    Novikova, A. I.
    Andreeva, O. V.
    Kuli-Zade, Z. A.
    Fashafsha, Zaki Z. A.
    Chomakhidze, P. Sh.
    Poltavskaya, M. G.
    [J]. KARDIOLOGIYA, 2023, 63 (10) : 91 - 94
  • [7] Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
    Amonoo, Hermioni L.
    Johnson, P. Connor
    Nelson, Ashley M.
    Clay, Madison A.
    Daskalakis, Elizabeth
    Newcomb, Richard A.
    Deary, Emma C.
    Mattera, Elizabeth F.
    Yang, Daniel
    Cronin, Katherine
    Lee, Stephanie J.
    LeBlanc, Thomas W.
    El-Jawahri, Areej
    [J]. BLOOD ADVANCES, 2023, 7 (07) : 1108 - 1116
  • [8] High-dose chemotherapy - High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia
    Anagnostopoulos, A
    Dimopoulos, MA
    Aleman, A
    Weber, D
    Alexanian, R
    Champlin, R
    Giralt, S
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 (10) : 1027 - 1029
  • [9] High-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) for patients with rhabdomyosarcomas (RMS)
    Peinemann, F.
    Hildebrandt, M.
    Kulig, M.
    Herrmann-Frank, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Polaprezinc Prevents Oral Mucositis in Patients Treated with High-dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
    Hayashi, Hiroko
    Kobayashi, Ryo
    Suzuki, Akio
    Ishihara, Masashi
    Nakamura, Nobuhiko
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Kitaichi, Kiyoyuki
    Hara, Takeshi
    Tsurumi, Hisashi
    Moriwaki, Hisataka
    Itoh, Yoshinori
    [J]. ANTICANCER RESEARCH, 2014, 34 (12) : 7271 - 7277
12345